Inmazeb 241.7 mg/14.5mL
atoltivimab, maftivimab, and odesivimab-ebgn · INJECTION, SOLUTION · Regeneron Pharmaceuticals, Inc.
Inmazeb is a injection, solution containing atoltivimab, maftivimab, and odesivimab-ebgn at 241.7 mg/14.5mL, taken intravenous. Manufactured by Regeneron Pharmaceuticals, Inc..
Key Facts
- Brand Name
- Inmazeb
- Generic Name
- atoltivimab, maftivimab, and odesivimab-ebgn
- NDC Code (Product)
61755-018- Manufacturer
- Regeneron Pharmaceuticals, Inc.
- Strength
- 241.7 mg/14.5mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761169
- Marketing Start
- 10/14/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is Inmazeb used for?
Inmazeb contains atoltivimab, maftivimab, and odesivimab-ebgn. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is Inmazeb a controlled substance?
Inmazeb is not classified as a controlled substance by the DEA.
What is the generic name for Inmazeb?
The generic name for Inmazeb is atoltivimab, maftivimab, and odesivimab-ebgn. There are no other listed brand versions of atoltivimab, maftivimab, and odesivimab-ebgn.
What is the NDC code for Inmazeb 241.7 mg/14.5mL?
The NDC (National Drug Code) for Inmazeb 241.7 mg/14.5mL is 61755-018, listed by Regeneron Pharmaceuticals, Inc..
Other Inmazeb Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)